官方服务：
资源简介：
List of TCRs reactive to the YeiH.232-240 antigen presented by HLA-B*27
应用场景：
提供机构：
Paley, Michael创建时间：
2024-07-19
相关数据集
Gene and protein sequence features augment HLA class I ligand predictions (mRNA sequencing)
The sensitivity of malignant tissues to T cell-based cancer immunotherapies is dependent on the presence of targetable HLA class I ligands on the tumor cell surface. Peptide intrinsic factors, such as
NIAID Data Ecosystem100
Known and potential epitopes in the conserved regions.
For each region, HLA types for which there are reported and predicted epitopes in the Los Alamos HIV Immunology Database (http://www.hiv.lanl.gov/content/sequence/ELF/epitope_analyzer.html) are listed
NIAID Data Ecosystem40
Association of Psoriasis with Alleles of HLA-C and CDSN.
aHLA-C allele designations follow the classification scheme of release 2.14.1 (Aug 2006) of the IMGT/HLA Sequence Database maintained by the HLA Informatics Group of the Anthony Nolan Research Institu
NIAID Data Ecosystem40
Table_2_Proportional Tumor Infiltration of T Cells via Circulation Duplicates the T Cell Receptor Repertoire in a Bilateral Tumor Mouse Model.xlsx
Temporal analysis of the T cell receptor (TCR) repertoire has been used to monitor treatment-induced changes in antigen-specific T cells in patients with cancer. However, the lack of experimental mode
NIAID Data Ecosystem50
HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Considering the well established role of nonclassical HLA-G class I molecules in inhibiting natural killer (NK) cell function, the consequence of abnormal HLA-G expression in malignant cells should be
PubMed Central1998-04-14 更新40
